Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added to the page footer. Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision history updated: a new entry for v3.4.1 was added and the existing entry for v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded UI controls to show/hide the glossary (Show glossary / Hide glossary). Updated metadata labels and version information, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with capitalization adjustments.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study information on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedA consolidated Locations section now lists Florida, Indiana, North Carolina, Tennessee, and Washington. The HHS Vulnerability Disclosure link was removed, and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check90 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. This change does not affect study content or user interactions.SummaryDifference0.1%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.